<SEC-DOCUMENT>0002088233-25-000004.txt : 20250926
<SEC-HEADER>0002088233-25-000004.hdr.sgml : 20250926
<ACCEPTANCE-DATETIME>20250926171653
ACCESSION NUMBER:		0002088233-25-000004
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250926
DATE AS OF CHANGE:		20250926

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lunai Bioworks Inc.
		CENTRAL INDEX KEY:			0001527728
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				452259340
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-86428
		FILM NUMBER:		251351421

	BUSINESS ADDRESS:	
		STREET 1:		CENTURY CITY MEDICAL PLAZA
		STREET 2:		2080 CENTURY CITY EAST
		CITY:			SUITE 906 LOS ANGELES
		STATE:			CA
		ZIP:			90067
		BUSINESS PHONE:		45 39179840

	MAIL ADDRESS:	
		STREET 1:		CENTURY CITY MEDICAL PLAZA
		STREET 2:		2080 CENTURY CITY EAST
		CITY:			SUITE 906 LOS ANGELES
		STATE:			CA
		ZIP:			90067

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RENOVARO INC.
		DATE OF NAME CHANGE:	20240213

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RENOVARO BIOSCIENCES INC.
		DATE OF NAME CHANGE:	20230807

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Enochian Biosciences Inc.
		DATE OF NAME CHANGE:	20230804

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Laksya Ventures Inc.
		CENTRAL INDEX KEY:			0002088233
		ORGANIZATION NAME:           	
		EIN:				262721444
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		406 OCEAN ONE LANE
		CITY:			NORTH PALM BEACH
		STATE:			FL
		ZIP:			33408
		BUSINESS PHONE:		212-841-6945

	MAIL ADDRESS:	
		STREET 1:		406 OCEAN ONE LANE
		CITY:			NORTH PALM BEACH
		STATE:			FL
		ZIP:			33408

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Laksya Ventures LLC
		DATE OF NAME CHANGE:	20250924
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002088233</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>07/07/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001527728</issuerCik>
        <issuerName>Lunai Bioworks Inc.</issuerName>
        <issuerCusip>236078101</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>CENTURY CITY MEDICAL PLAZA</com:street1>
          <com:street2>2080 CENTURY CITY EAST</com:street2>
          <com:city>SUITE 906 LOS ANGELES</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>90067</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Laksya Ventures Inc.</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>22163978.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>22163978.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>22163978.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>9.6</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>1. Represents 18,997,168 Shares held by Laksya Ventures, Inc. ("Laksya Ventures") that were issued upon conversion of convertible notes as reflected on the Form 8-K of Lunai Bioworks, Inc., a Delaware corporation ("Issuer"), filed with the SEC on July 9, 2025, 500,000 shares of common stock held directly by Laksya Ventures, and 2,666,810 shares of common stock held by Mr. Persh. Laksya Ventures is beneficially owned and controlled by Mr. Persh, who exercises sole voting and investment power.
2. Based on 230,928,963 shares of common stock, $0.0001 par value per share, issued and outstanding as of July 15, 2025, as per the Issuer's Schedule 14A filed with the SEC on July 30, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Neil Persh</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>22163978.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>22163978.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>22163978.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>9.6</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>1. Represents 18,997,168 Shares held by Laksya Ventures Inc., ("Laksya Ventures") that were issued upon conversion of convertible notes as reflected on the Form 8-K of Lunai Bioworks, Inc., a Delaware corporation ("Issuer"), filed with the SEC on July 9, 2025, 500,000 shares of common stock held directly by Laksya Ventures, and 2,666,810 shares of common stock held by Mr. Persh. Laksya Ventures is beneficially owned and controlled by Mr. Persh, who exercises sole voting and investment power.
2. Based on 230,928,963 shares of common stock, $0.0001 par value per share, issued and outstanding as of July 15, 2025, as per the Issuer's Schedule 14A filed with the SEC on July 30, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Lunai Bioworks Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>CENTURY CITY MEDICAL PLAZA, 2080 CENTURY CITY EAST, SUITE 906 LOS ANGELES, CALIFORNIA, 90067.</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This Schedule 13G is being jointly filed by Laksya Ventures Inc., a New York corporation ("Laksya Ventures"), and Neil Persh ("Mr. Persh" and, together with Laksya Ventures, collectively, the "Reporting Persons").

Laksya Ventures is a corporation owned and controlled by Mr. Persh, and in such capacity, exercises the sole voting and investment power over the Shares of the Company held for the account of Laksya Ventures. </filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>888 7th Avenue, 40th Floor, New York, NY 10019</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Laksya Ventures is a New York corporation. Mr. Persh is a citizen of the United States of America.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>All percentages of Shares outstanding contained herein are based on 230,928,963 Shares of the Company issued and outstanding as of July 15, 2025, as disclosed on the Company's Schedule 14A filed with the SEC on July 30, 2025.
As of the date hereof, Laksya Ventures may be deemed to have beneficial ownership of 22,163,978 Shares.
As of the date hereof, Mr. Persh may be deemed to have beneficial ownership of 22,163,978 Shares, representing 2,666,810 Shares held directly by Mr. Persh and 19,497,168 Shares held by Laksya Ventures.</amountBeneficiallyOwned>
        <classPercent>The Shares beneficially owned by the Reporting Persons represent 9.6% of the total outstanding Shares.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>Mr. Persh may be deemed to have the sole power to vote or direct the vote of all of the 22,163,978 Shares.</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>Laksya Ventures may be deemed to share the power to vote or direct the vote of all of the 22,163,978 Shares with Mr. Persh.</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>Mr. Persh may be deemed to have the sole power to dispose or direct the disposition of all of the 22,163,978 Shares.</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>Laksya Ventures may be deemed to share the power to dispose or direct the disposition of all of the 22,163,978 Shares.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
        <classOwnership5PercentOrLess>N</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under &amp;#167; 240.14a-11.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Laksya Ventures Inc.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Neil Persh</signature>
        <title>Chief Executive Officer</title>
        <date>09/26/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Neil Persh</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Neil Persh</signature>
        <title>Self</title>
        <date>09/26/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
